http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-442-Y1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_380c086e0dccfe812e0267649e60d49d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15df97a4eeb3bad72d8d04e3bfe6cf97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_725a33e338952c31f492777488bed2da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1ffa04ad84f417a08c20787eedd2579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b76bfe49d93f55c0959dd8f2d902c31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_457d234fc7d06d7c63887c4d95c007f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_792541a1ec172de18e8baab7d7a521b1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1835f3a752600cdecc4c90d0ccff12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7a30f400ba1dd77b00026d0b239bc46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1e3dcf6ddb99822317d752dd4d67558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254f1a3f5dbfcc655f3e17cef2bab553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7666cb2543a6e655d8baeaff86057729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68a652f287ecfbe0c273be52d904a177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08fa008d415d3707e116571c43c66ec
publicationDate 2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-442-Y1
titleOfInvention PHARMACEUTICAL FORM WITH ANTIBODY ACTION
abstract The medicamentous form can be used in the treatment of acute and chronic bronchitis. It has the advantages of the liquid forms and has better facilities for storage, shipment and usage. It contains, in wt. pts.: glaucin hydrobromide 0.05-0.30, isomer of ephedrin hydrochloride 0.01-0,35, sweet basic oil 0.01-0,20, citric acid 0.01-2.00, sweetener from 15.0 to 45.0, surfactant from 0.50 to 5.00 or a combination thereof with hydrophilic lipophil from 10 to 18 0.50-5.0, which additionally contains alcohol and preservatives in the form of powder in which the ratio between the fraction with particle sizes under 0.3 mm and that of from 0.3 to 2.00 mm is 1:4. Semi-solid peroral medicamentous form - gel, is produced by the addition of a condenser from 0,5 to 1.5 wt. pts. and treated water in ration to the powder from 1:2 to 2:1. 4 claims
priorityDate 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448423516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447768973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447768971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311

Total number of triples: 52.